The Food and Drug Administration (FDA) has sent warning letters to multiple companies involved in the distribution of products containing cannabidiol (CBD). fdaThe FDA sent warning letters today to four CBD-related companies claiming them to be making unsubstantiated claims “related to more than 25 different products spanning multiple product webpages, online stores and social media …
The government is seeking public comments on a variety of substances, including the cannabis-derived compound cannabidiol, commonly referred to as CBD. Specifically, the Food and Drug Administration (FDA) is “requesting interested persons to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of 17 …
Tennessee’s governor has signed into law a bill that allows the medical use of cannabidiol (CBD) after FDA approval. Senate Bill 385 was signed into law today by Governor Bill Haslam. The measure was approved unanimously through both the House of Representatives (90 to 0) and Senate (33 to 0); it took effect immediately upon …
The Tennessee Legislature has passed a bill to allow the medical use of cannabidiol (CBD) after FDA approval. House Bill 694 passed the Senate earlier this month with a 33 to 0 vote, and today passed the House with a vote of 90 to 0. It will now be sent to Governor Bill Haslam for …
According to Rachel Maddow, Trump is “close to naming” Jim O’Neil as head of the Food and Drug Administration (FDA). O’Neil is not only a supporter of legalizing marijuana, he has publicly worked towards it. He previously served on the Board of Directors for the Coalition for Cannabis Policy Reform (CCPR). According to their website, …
Sean Spicer, President Donald Trump’s Press Secretary, has confirmed previous reports that Jim O’Neil is being considered to lead the Food and Drug Administration. O’Neil is not only a strong supporter of legalizing marijuana, he has actively worked towards it as a Board of Directors member for the Coalition for Cannabis Policy Reform, which helped …
By Paul Armentano, NORML Deputy Director The administration of cannabis oil extracts high in cannabidiol reduces seizure frequency in children with intractable epilepsy, according to clinical data published online ahead of print in the journal Seizure. Israeli researchers retrospectively evaluated the effects of CBD oil in a multicenter cohort of 74 patients with intractable epilepsy. …
GW Pharmaceuticals, a biopharmaceutical company with a focus on cannabinoid-based medicines, has received fast track approval from the U.S. Food and Drug Administration (FDA) for a medicine designed to treat newborns deprived of oxygen during childbirth, which can lead to brain damage and death. The FDA gave approval to an intravenous form of cannabidiol (CBD) …
Arkansas Governor Asa Hutchinson and Wyoming Governor Matt Mead have both signed into law bills that nullify some FDA (Food and Drug Administration) restrictions that prevent terminally ill patients from using experimental treatments. Senate Bill 4 (Arkansas) and Senate File 3 (Wyoming) would both allow a patient suffering from a terminal disease who has considered …
The University of Alabama has received approval from the Food and Drug Administration (FDA) to begin cultivating, administering and studying the impact of low-THC (tetrahydrocannabinol), high-CBD (cannabidiol) cannabis extracts on childhood and adult seizure disorders. In April, Alabama Governor Robert Bentley signed into law Senate Bill 174 which authorizes the University of Alabama’s Department of …
